PTK2 and breast cancer: Moreover, it has been reported that FAK inhibition or silencing impairs the tumorsphere-forming ability of different breast cancer models, including MDA-MB-231 and other TNBC cell lines [67,72,73], and breast cancer cells from patients [74], which could explain the decreased number of tumorspheres following TENM4 silencing.